The table below shows BeOne Medicines AG's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
-
-
-
-
-
-
Cost of revenue
-
-
-
-
-
-
Gross profit
$1.35B
$1.22B
$1.15B
$952.28M
$831.14M
$791.03M
R&D
$541.22M
$523.66M
$524.90M
$481.89M
$496.18M
$454.47M
ONC annual revenue (10-K history)
BeOne Medicines AG reported annual revenue of $5.34B for fiscal year 2025. That is up 40.2% from $3.81B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $1.07M (FY 2016) to $5.34B. Figures come from the company's audited annual reports as filed with the SEC.